Tetracycline and fluoroquinolone resistance in clinical Ureaplasma spp. and Mycoplasma hominis isolates in France between 2010 and 2015

Objectives As information on Ureaplasma spp. and Mycoplasma hominis resistance is currently limited, the aim of this study was to investigate the susceptibility of Ureaplasma spp. and M. hominis to tetracyclines and fluoroquinolones in France. Methods The susceptibility of 1014 clinical isolates obtained in Bordeaux University Hospital (Bordeaux, France) between 2010 and 2015 was evaluated using two commercial kits, S.I.R. Mycoplasma (Bio-Rad) from 1 January 2010 to 5 October 2012 and MYCOFAST RevolutioN kit (ELITech Group) from 6 October 2012 to 31 December 2015. The MICs of isolates designated as resistant were determined using the broth microdilution assay. Additionally, the tet(M) gene and fluoroquinolone resistance-associated mutations were identified. Results Among 831 Ureaplasma spp. isolates, the tetracycline, levofloxacin and moxifloxacin resistance rates were 7.5%, 1.2% and 0.1%, respectively. Among 183 M. hominis isolates, the resistance rates were 14.8%, 2.7% and 1.6% for tetracycline, levofloxacin and moxifloxacin, respectively. Over the 6 year period, no significant change in resistance to tetracycline or fluoroquinolones was observed. The tet(M) gene was found in all tetracycline-resistant isolates. All levofloxacin-resistant isolates harboured a mutation in the parC or parE genes. Isolates that were also resistant to moxifloxacin harboured an additional mutation in the gyrA gene. The MYCOFAST RevolutioN kit significantly overestimated levofloxacin and moxifloxacin resistance in Ureaplasma spp. isolates. Conclusions Resistance to tetracycline and fluoroquinolones is limited in France in mycoplasmas but compared with a previous report in 1999-2002, a significant increase in tetracycline resistance among Ureaplasma spp. was observed. Ongoing monitoring of the antibiotic susceptibility of these urogenital mycoplasmas remains necessary.

[1]  O. B. Spiller,et al.  Antibiotic resistance among Ureaplasma spp. isolates: cause for concern? , 2017, The Journal of antimicrobial chemotherapy.

[2]  Robin Patel,et al.  Antimicrobial Susceptibility and Clonality of Clinical Ureaplasma Isolates in the United States , 2016, Antimicrobial Agents and Chemotherapy.

[3]  V. Chalker,et al.  Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013 , 2015, Antimicrobial Agents and Chemotherapy.

[4]  T. Bodmer,et al.  Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland , 2015, Antimicrobial Agents and Chemotherapy.

[5]  M. Nakayama,et al.  In Vitro Activity of Five Quinolones and Analysis of the Quinolone Resistance-Determining Regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum Clinical Isolates from Perinatal Patients in Japan , 2015, Antimicrobial Agents and Chemotherapy.

[6]  Wen-cheng Xue,et al.  Molecular mechanism of fluoroquinolones resistance in Mycoplasma hominis clinical isolates , 2014, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[7]  H. Lombaard,et al.  Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women , 2014, BMC Infectious Diseases.

[8]  J. Glass,et al.  Chromosomal Mutations Responsible for Fluoroquinolone Resistance in Ureaplasma Species in the United States , 2012, Antimicrobial Agents and Chemotherapy.

[9]  Alain Blanchard,et al.  Life on Arginine for Mycoplasma hominis: Clues from Its Minimal Genome and Comparison with Other Human Urogenital Mycoplasmas , 2009, PLoS genetics.

[10]  S. Kotecha,et al.  Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism. , 2009, The Journal of antimicrobial chemotherapy.

[11]  S. Pereyre,et al.  Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  A. Charron,et al.  Tetracycline Resistance in Ureaplasma spp. and Mycoplasma hominis: Prevalence in Bordeaux, France, from 1999 to 2002 and Description of Two tet(M)-Positive Isolates of M. hominis Susceptible to Tetracyclines , 2007, Antimicrobial Agents and Chemotherapy.

[13]  Jun Zhang,et al.  Trends in the rates of resistance of Ureaplasma urealyticum to antibiotics and identification of the mutation site in the quinolone resistance-determining region in Chinese patients. , 2006, FEMS microbiology letters.

[14]  J. Glass,et al.  Fluoroquinolone Resistance in Ureaplasma parvum in the United States , 2006, Journal of Clinical Microbiology.

[15]  B. Yoon,et al.  Detection and biovar discrimination of Ureaplasma urealyticum by real-time PCR. , 2005, Molecular and cellular probes.

[16]  D. Gruson,et al.  In Vitro Development of Resistance to Six and Four Fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, Respectively , 2005, Antimicrobial Agents and Chemotherapy.

[17]  S. Pereyre,et al.  In Vitro Activities of the Newer Quinolones Garenoxacin, Gatifloxacin, and Gemifloxacin against Human Mycoplasmas , 2004, Antimicrobial Agents and Chemotherapy.

[18]  S. Pereyre,et al.  DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of Ureaplasma spp. and Mycoplasma hominis Resistant to Fluoroquinolones , 2003, Antimicrobial Agents and Chemotherapy.

[19]  D. Gruson,et al.  In Vitro Activity of Trovafloxacin Compared to Those of Five Antimicrobials against Mycoplasmas IncludingMycoplasma hominis and Ureaplasma urealyticumFluoroquinolone-Resistant Isolates That Have Been Genetically Characterized , 2000, Antimicrobial Agents and Chemotherapy.

[20]  T. Schaeverbeke,et al.  Mutations in the gyrA, parC, and parE Genes Associated with Fluoroquinolone Resistance in Clinical Isolates of Mycoplasma hominis , 1999, Antimicrobial Agents and Chemotherapy.

[21]  C. Bébéar,et al.  Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones , 1997, Antimicrobial agents and chemotherapy.

[22]  M. Dupon,et al.  A Tn1545-like transposon carries the tet(M) gene in tetracycline resistant strains of Bacteroides ureolyticus as well as Ureaplasma urealyticum but not Neisseria gonorrhoeae. , 1996, The Journal of antimicrobial chemotherapy.